CMRX News

News
all
press releases
Following the news, JonesResearch raised its price target on Chimerix to $7 from $5 while maintaining a ‘Buy’ rating.
Stocktwits
Emergent Biosolutions and Chimerix also saw marginal gains after the announcement.
Stocktwits
The monkeypox outbreak has boosted stocks of GeoVax Labs, Tonix Pharmaceuticals, and Chimerix. These companies are developing vaccines and treatments related to smallpox and viral diseases, positioning them as key players in addressing this health crisis.
Sponsored

Advertisement|Remove ads.